Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-12-031730
Filing Date
2012-06-01
Accepted
2012-06-01 17:49:21
Documents
2
Period of Report
2012-06-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2209
2 POA DOCUMENT poa.txt EX-24.3_427120 4013
  Complete submission text file 0001209191-12-031730.txt   7562
Mailing Address 249 E. GRAND AVE. SOUTH SAN FRANCISCO CA 94080
Business Address 249 E. GRAND AVE. SOUTH SAN FRANCISCO CA 94080 650-266-0000
ONYX PHARMACEUTICALS INC (Issuer) CIK: 0001012140 (see all company filings)

EIN.: 943154463 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 145 BRANDYWINE PKWY WEST CHESTER PA 19380
Business Address
OSBORN JOHN E (Reporting) CIK: 0001209721 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-28298 | Film No.: 12884365